Generation Bio Co. Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Revenue	9.96	5.9	0	0	0	0	Upgrade
Gross Profit	9.96	5.9	0	0	0	0	Upgrade
Selling, General & Admin	48.41	50.85	44.46	33.85	22.58	12.17	Upgrade
Research & Development	85.95	93.62	96.72	85.25	58.53	50.13	Upgrade
Other Operating Expenses	56.93	0	0	0	0	0	Upgrade
Operating Expenses	191.29	144.47	141.18	119.1	81.11	62.3	Upgrade
Operating Income	-181.33	-138.56	-141.18	-119.1	-81.11	-62.3	Upgrade
Other Expense / Income	-12.27	-11.95	-4.54	0.05	-0.59	-0.99	Upgrade
Pretax Income	-169.06	-126.61	-136.64	-119.15	-80.52	-61.32	Upgrade
Net Income	-169.06	-126.61	-136.64	-119.15	-80.52	-61.32	Upgrade
Shares Outstanding (Basic)	66	64	58	56	27	5	Upgrade
Shares Outstanding (Diluted)	66	64	58	56	27	5	Upgrade
Shares Change	10.30%	10.96%	3.23%	106.54%	476.06%	41.22%	Upgrade
EPS (Basic)	-2.55	-1.96	-2.35	-2.12	-2.95	-12.96	Upgrade
EPS (Diluted)	-2.55	-1.96	-2.35	-2.12	-2.95	-12.96	Upgrade
Free Cash Flow	-65.33	-60.14	-111.25	-97.67	-75.66	-60.25	Upgrade
Free Cash Flow Per Share	-0.98	-0.93	-1.91	-1.74	-2.78	-12.73	Upgrade
Gross Margin	100.00%	100.00%	-	-	-	-	Upgrade
Operating Margin	-1820.04%	-2346.93%	-	-	-	-	Upgrade
Profit Margin	-1696.87%	-2144.51%	-	-	-	-	Upgrade
Free Cash Flow Margin	-655.68%	-1018.67%	-	-	-	-	Upgrade
EBITDA	-163.81	-121.35	-131.51	-114.62	-77.09	-59.45	Upgrade
EBITDA Margin	-1644.22%	-2055.37%	-	-	-	-	Upgrade
Depreciation & Amortization	5.25	5.26	5.13	4.53	3.43	1.86	Upgrade
EBIT	-169.06	-126.61	-136.64	-119.15	-80.52	-61.32	Upgrade
EBIT Margin	-1696.87%	-2144.51%	-	-	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).